Skip to main content
SpringerLink
Log in

Adrenal insufficiency treated with conventional hydrocortisone leads to elevated levels of Interleukin-6: a pilot study

  • Research Letter
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. A.C. Willis, F.P. Vince, The prevalence of Addison’s disease in Coventry, UK. Post. Med. J. 73, 286–288 (1997)

    Article  CAS  Google Scholar 

  2. H.J. Schneider, G. Aimaretti, I. Kreitschmann-Andermahr, G.K. Stalla, E. Ghigo, Hypopituitarism. Lancet 369, 1461–1470 (2007)

    Article  CAS  PubMed  Google Scholar 

  3. S.R. Bornstein, B. Allolio, W. Arlt, A. Barthel, A. Don-Wauchope, G.D. Hammer et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 364–389 (2016)

    Article  CAS  PubMed  Google Scholar 

  4. A.H. Rahvar, C.S. Haas, S. Danneberg, B. Harbeck, Increased cardiovascular risk in patients with adrenal insufficiency: a short review. Biomed. Res. Int. 2017, 3691913 (2017)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. B. Harbeck, P. Kropp, H. Mönig, Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study. Appl. Psychophysiol. Biofeedback 34, 113–119 (2009)

    Article  PubMed  Google Scholar 

  6. H. Filipsson, J.P. Monson, M. Koltowska-Häggström, A. Mattsson, G. Johannsson, The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J. Clin. Endocrinol. Metab. 91, 3954–3961 (2006)

    Article  CAS  PubMed  Google Scholar 

  7. M. Debono, R.J. Ross, J. Newell-Price, Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. Eur. J. Endocrinol. 160, 719–729 (2009)

    Article  CAS  PubMed  Google Scholar 

  8. G. Mastorakos, G. Paltoglou, M. Greene, I. Ilias, A. Papamichalopoulos, S. Dimopoulos et al. Inappropriately normal plasma ACTH and cortisol concentrations in the face of increased circulating interleukin-6 concentration in exercise in patients with sarcoidosis. Stress 16, 202–210 (2013)

    Article  CAS  PubMed  Google Scholar 

  9. D.A. Papanicolaou, C. Tsigos, E.H. Oldfield, G.P. Chrousos, Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency? J. Clin. Endocrinol. Metab. 81, 2303–2306 (1996)

    Article  CAS  PubMed  Google Scholar 

  10. C. Tsigos, I. Kyrou, G.P. Chrousos, D.A. Papanicolaou, Prolonged suppression of corticosteroid-binding globulin by recombinant human interleukin-6 in man. J. Clin. Endocrinol. Metab. 83, 3379 (1998)

    Article  CAS  PubMed  Google Scholar 

  11. N. Sarwar et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 379, 1205–1213 (2012)

    Article  CAS  PubMed  Google Scholar 

  12. D.I. Swerdlow et al. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet 379, 1214–1224 (2012)

    Article  CAS  PubMed  Google Scholar 

  13. M. Forss, G. Batcheller, S. Skrtic, G. Johannsson, Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency—a worldwide patient survey. BMC Endocr. Disord. 12, 8 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. G. Johannsson, A.G. Nilsson, R. Bergthorsdottir, P. Burman, P. Dahlqvist, B. Ekman et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J. Clin. Endocrinol. Metab. 97, 473–481 (2012)

    Article  CAS  PubMed  Google Scholar 

  15. A.M. Isidori, M.A. Venneri, C. Graziadio, C. Simeoli, D. Fiore, V. Hasenmajer et al. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 6, 173–185 (2018)

    Article  CAS  PubMed  Google Scholar 

  16. P.M. Ridker, N. Rifai, M.J. Stampfer, C.H. Hennekens, Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101, 1767–1772 (2000)

    Article  CAS  PubMed  Google Scholar 

  17. B.C. Bacchiega, A.B. Bacchiega, M.J. Usnayo, R. Bedirian, G. Singh, G.D. Pinheiro, Interleukin 6 inhibition and coronary artery disease in a high-risk population: a prospective community-based clinical study. J. Am. Heart Assoc. 6, e005038 (2017)

    Article  PubMed  PubMed Central  Google Scholar 

  18. L. Brydon, S. Edwards, V. Mohamed-Ali, A. Steptoe, Socioeconomic status and stress-induced increases in interleukin-6. Brain Behav. Immun. 18, 281–290 (2004)

    Article  CAS  PubMed  Google Scholar 

  19. R. von Känel, B.M. Kudielka, D. Preckel, D. Hanebuth, J.E. Fischer, Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men. Brain Behav. Immun. 20, 40–48 (2006)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    Amir-Hossein Rahvar

  2. University of Luebeck, Luebeck, Germany

    Martin Riesel & Birgit Harbeck

  3. Department of Cardiology, University Hospital Luebeck, Luebeck, Germany

    Tobias Graf

  4. MVZ Amedes Experts, Endocrinology, Hamburg, Germany

    Birgit Harbeck

Authors
  1. Amir-Hossein Rahvar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Riesel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tobias Graf
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Birgit Harbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amir-Hossein Rahvar.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rahvar, AH., Riesel, M., Graf, T. et al. Adrenal insufficiency treated with conventional hydrocortisone leads to elevated levels of Interleukin-6: a pilot study. Endocrine 64, 727–729 (2019). https://doi.org/10.1007/s12020-019-01956-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-019-01956-3

Search

Navigation